BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25062732)

  • 1. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
    Aylward EH; Harrington DL; Mills JA; Nopoulos PC; Ross CA; Long JD; Liu D; Westervelt HK; Paulsen JS;
    J Huntingtons Dis; 2013; 2(4):477-89. PubMed ID: 25062732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
    Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
    J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease.
    Harrington DL; Liu D; Smith MM; Mills JA; Long JD; Aylward EH; Paulsen JS
    Brain Behav; 2014 Jan; 4(1):29-40. PubMed ID: 24653952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.
    Jurgens CK; van de Wiel L; van Es AC; Grimbergen YM; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
    J Neurol; 2008 Nov; 255(11):1785-91. PubMed ID: 19156490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal change in regional brain volumes in prodromal Huntington disease.
    Aylward EH; Nopoulos PC; Ross CA; Langbehn DR; Pierson RK; Mills JA; Johnson HJ; Magnotta VA; Juhl AR; Paulsen JS;
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):405-10. PubMed ID: 20884680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
    Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
    Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcortical Atrophy in Cognitive Impairment and Dementia.
    Hilal S; Amin SM; Venketasubramanian N; Niessen WJ; Vrooman H; Wong TY; Chen C; Ikram MK
    J Alzheimers Dis; 2015; 48(3):813-23. PubMed ID: 26402115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.
    Politis M; Pavese N; Tai YF; Kiferle L; Mason SL; Brooks DJ; Tabrizi SJ; Barker RA; Piccini P
    Hum Brain Mapp; 2011 Feb; 32(2):258-70. PubMed ID: 21229614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.
    Aylward EH; Liu D; Nopoulos PC; Ross CA; Pierson RK; Mills JA; Long JD; Paulsen JS;
    Biol Psychiatry; 2012 May; 71(9):822-8. PubMed ID: 21907324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
    Scahill RI; Hobbs NZ; Say MJ; Bechtel N; Henley SM; Hyare H; Langbehn DR; Jones R; Leavitt BR; Roos RA; Durr A; Johnson H; Lehéricy S; Craufurd D; Kennard C; Hicks SL; Stout JC; Reilmann R; Tabrizi SJ;
    Hum Brain Mapp; 2013 Mar; 34(3):519-29. PubMed ID: 22102212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
    van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
    J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
    Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
    Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
    Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
    Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.
    Misiura MB; Ciarochi J; Vaidya J; Bockholt J; Johnson HJ; Calhoun VD; Paulsen JS; Turner JA;
    J Int Neuropsychol Soc; 2019 May; 25(5):462-469. PubMed ID: 30806337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.